GlassScriptPhysician profile
Ronald Shin
NPI 1275933079
$19,295.02
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $666 · 2021: $250 · 2022: $207 · 2023: $11K · 2024: $6,725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $4,700 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $200 · Food and Beverage: $13.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,125.00 |
| Travel and Lodging | $4,699.86 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $200.00 |
| Food and Beverage | $13.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tg Therapeutics, INC. | $18,024.86 | 2023-2024 | |
| Medtronic, INC. | $379.06 | 2021-2022 | |
| Medtronic USA, INC. | $310.20 | 2020 | |
| Boston Scientific Corporation | $260.75 | 2019-2021 | |
| Biodelivery Sciences International, INC. | $175.53 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $98.85 | 2019-2020 | |
| Redhill Biopharma INC. | $17.07 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.07 | 2020 | |
| Pfizer INC. | $13.63 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Shin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.